Cohen, Lital and Assaraf, Yehuda G. and Livney, Yoav D. (2021) Novel Selectively Targeted Multifunctional Nanostructured Lipid Carriers for Prostate Cancer Treatment. Pharmaceutics, 14 (1). p. 88. ISSN 1999-4923
![[thumbnail of pharmaceutics-14-00088.pdf]](http://publish7promo.com/style/images/fileicons/text.png)
pharmaceutics-14-00088.pdf - Published Version
Download (6MB)
Abstract
Prostate cancer (PC) is the most common cancer in men over 50 and the 4th most prevalent human malignancy. PC treatment may include surgery, androgen deprivation therapy, chemotherapy, and radiation therapy. However, the therapeutic efficacy of systemic chemotherapy is limited due to low drug solubility and insufficient tumor specificity, inflicting toxic side effects and frequently provoking the emergence of drug resistance. Towards the efficacious treatment of PC, we herein developed novel selectively PC-targeted nanoparticles (NPs) harboring a cytotoxic drug cargo. This delivery system is based upon PEGylated nanostructured lipid carriers (NLCs), decorated with a selective ligand, targeted to prostate-specific membrane antigen (PSMA). NPs loaded with cabazitaxel (CTX) displayed a remarkable loading capacity of 168 ± 3 mg drug/g SA-PEG, encapsulation efficiency of 67 ± 1%, and an average diameter of 159 ± 3 nm. The time-course of in vitro drug release from NPs revealed a substantial drug retention profile compared to the unencapsulated drug. These NPs were selectively internalized into target PC cells overexpressing PSMA, and displayed a dose-dependent growth inhibition compared to cells devoid of the PSMA receptor. Remarkably, these targeted NPs exhibited growth-inhibitory activity at pM CTX concentrations, being markedly more potent than the free drug. This selectively targeted nano-delivery platform bears the promise of enhanced efficacy and minimal untoward toxicity.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | prostate cancer; nanoparticles; nanostructured lipid carriers; prostate-specific membrane antigen; targeted delivery; encapsulation; cabazitaxel |
Subjects: | Euro Archives > Medical Science |
Depositing User: | Managing Editor |
Date Deposited: | 10 Nov 2022 05:13 |
Last Modified: | 15 Sep 2023 06:23 |
URI: | http://publish7promo.com/id/eprint/92 |